However, CDK6 overexpression has been shown to reduce tumorigenesis in melanoma and B cell lymphoma27,28, while suppression of CDK6 leads to suppression of tumor cell growth in acute myeloid leukemia29, colorectal cancer30, and breast cancer31. The gene discussed is CDK6; the disease is neoplasm.